Mercer Global Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,676
| Closed | -$237K | – | 2093 |
|
|
2023
Q4 | $237K | Sell |
4,676
-420
| -8% | -$21.3K | ﹤0.01% | 1745 |
|
|
2023
Q3 | $231K | Sell |
5,096
-267
| -5% | -$12.1K | ﹤0.01% | 1692 |
|
|
2023
Q2 | $220K | Buy |
+5,363
| New | +$220K | ﹤0.01% | 1693 |
|
|
2022
Q3 | – | Sell |
-5,396
| Closed | -$200K | – | 1871 |
|
|
2022
Q2 | $200K | Buy |
+5,396
| New | +$200K | ﹤0.01% | 1636 |
|
|
2020
Q1 | – | Sell |
-3,449
| Closed | -$208K | – | 1174 |
|
|
2019
Q4 | $208K | Sell |
3,449
-893
| -21% | -$53.9K | ﹤0.01% | 1070 |
|
|
2019
Q3 | $260K | Sell |
4,342
-446
| -9% | -$26.7K | 0.01% | 938 |
|
|
2019
Q2 | $308K | Buy |
4,788
+1,749
| +58% | +$113K | 0.01% | 866 |
|
|
2019
Q1 | $247K | Buy |
+3,039
| New | +$247K | 0.01% | 906 |
|